Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Poseltinib by Hanmi Pharmaceuticals for Follicular Lymphoma: Likelihood of Approval
Poseltinib is under clinical development by Hanmi Pharmaceuticals and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase...
Poseltinib by Hanmi Pharmaceuticals for Autoimmune Disorders: Likelihood of Approval
Poseltinib is under clinical development by Hanmi Pharmaceuticals and currently in Phase II for Autoimmune Disorders. According to GlobalData, Phase...
Poseltinib by Hanmi Pharmaceuticals for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Poseltinib is under clinical development by Hanmi Pharmaceuticals and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to...